Beese Fulmer Investment Management Inc. Has $376,000 Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Beese Fulmer Investment Management Inc. decreased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 6.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,863 shares of the company’s stock after selling 346 shares during the period. Beese Fulmer Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $376,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Meitav Investment House Ltd. acquired a new stake in GE HealthCare Technologies during the second quarter worth $113,000. Pin Oak Investment Advisors Inc. acquired a new stake in GE HealthCare Technologies during the second quarter worth $25,000. Resources Management Corp CT ADV acquired a new stake in GE HealthCare Technologies during the second quarter worth $28,000. First Command Advisory Services Inc. boosted its stake in GE HealthCare Technologies by 36,900.0% during the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after buying an additional 369 shares in the last quarter. Finally, Householder Group Estate & Retirement Specialist LLC acquired a new stake in GE HealthCare Technologies during the third quarter worth $26,000. Institutional investors and hedge funds own 79.18% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on GEHC shares. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $66.00 to $88.00 in a research note on Monday, February 12th. Mizuho boosted their target price on shares of GE HealthCare Technologies from $94.00 to $96.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. Jefferies Financial Group started coverage on shares of GE HealthCare Technologies in a research note on Thursday, November 30th. They issued a “hold” rating and a $80.00 target price on the stock. Morgan Stanley boosted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research note on Monday, February 12th. Finally, HSBC started coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $88.73.

Get Our Latest Stock Report on GEHC

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $89.41 on Friday. The stock has a 50-day simple moving average of $82.41 and a 200 day simple moving average of $74.16. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50. The stock has a market capitalization of $40.71 billion, a price-to-earnings ratio of 29.61, a P/E/G ratio of 3.08 and a beta of 0.97.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. During the same period in the previous year, the business posted $1.31 earnings per share. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Featured Articles

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.